Partners

BBMR-LPC is a European-wide project involving 30 partners from 17 countries. The coordination is led co-jointly by the Finnish Institute for Molecular Medicine FIMM / University of Helsinki, and Leiden University Medical Center (LUMC). Other partners involved are universities, research centers, - agencies or - institutes and private sectors that offer expertise in science, technology, ethical and legal aspects.

Partners

1 University of Helsinki, FI
2 Leiden University Medical Center, NL
3 International Agency for Research on Cancer, FR
4 Imperial College London, UK
5 Medical University of Graz, AT
6 Karolinska Institute, SE
7 Wellcome Trust Sanger Institute, UK
8 University Medical Center Groningen, NL
9 Helmholtz Center Munich, DE
10 Norwegian University of Science and Technology, NO
11 Tartu University, EE
12 Uppsala University, SE
13 CNAG - Centro Nacional de Análisis Genómico, ES [administrated by Fundacio Centre Regulacio Genomica (CRG) from July 1st 2015]
14 Cambridge Protein Arrays Ltd, UK
15 University of PECS, HU
16 University of Leicester, UK (terminated participation 30/09/2013)
17 The Research Institute of the McGill University Health Centre, CA
18 Legal Pathways Institute for Health and Bio-Law, NL
19 deCODE Genetics, IS
20 The National Institute for Health and Welfare, FI
21 International Prevention Research Institute - iPRI, FR
22 Latvian Biomedical Research and Study Centre, LV
23 Split University School of Medicine, HR
24 Wroclawskie Centrum Badan EIT+, PL
25 Technical University Munich-Department of Medicine, DE
26 Institut National de la Sante Et de la Recherche Medicale (INSERM), FR
27 Medlaw Consult, NL
28 Maastricht University, NL
29 Norwegian Institute of Public Health, NO
30 The State Serum Institute, DK
31 University of Bristol, UK
32 BBMRI-ERIC (Biobanking and BioMolecular Resources Research Infrastructure-ERIC), AT
33 University of Milano-Bicocca, IT